S 4191
116th Congress
Senate
Health
Congressional oversight
Genetics
Government information and archives
Government studies and investigations
Health technology, devices, supplies
Industrial policy and productivity
Manufacturing
Prescription drugs
Retail and wholesale trades
U.S. and foreign investments
United States Pharmaceutical Supply Chain Review Act
Introduced: July 2, 2020
Introduced by:
Warren, Elizabeth
Democratic
· Massachusetts
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 2, 2020
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Jul 2, 2020
Introduced in Senate
Plain-English summary
United States Pharmaceutical Supply Chain Review Act
This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
What's happening now
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Committees of jurisdiction
1